Carmen Romero

ORCID: 0000-0002-9818-8923 · 5 papers in corpus · active 1987-2019

Study types

  • article 4
  • review 1

Condition tags

  • dysmenorrhea 1
  • endometriosis 1
review 2019
Angiogenesis in Gynecological Cancers: Role of Neurotrophins
·doi:10.3389/fonc.2019.00913

Angiogenesis, or generation of new blood vessels from other pre-existing, is a key process to maintain the supply of nutrients and oxygen in tissues. Unfortunately, this process is exacerbated in pathologies such as retinopathies and cancer…

article 2015
Levels of Regulatory Proteins Associated With Cell Proliferation in Endometria From Untreated Patients Having Polycystic Ovarian Syndrome With and Without Endometrial Hyperplasia
·doi:10.1177/1933719115597762
article 2009
Nerve Growth Factor Induces Vascular Endothelial Growth Factor Expression in Granulosa Cells via a trkA Receptor/Mitogen-Activated Protein Kinase-Extracellularly Regulated Kinase 2-Dependent Pathway
·doi:10.1210/jc.2009-0542

CONTEXT: Acquisition of ovulatory competence by antral follicles requires development of an adequate vascular supply. Although it is well established that ovarian angiogenesis is cyclically regulated by vascular endothelial growth factor (V…

article 1992
[The gestrinone (R-2323) treatment of endometriosis].
Revista chilena de obstetricia y ginecologia

Results of medical treatment with gestrinone are evaluated in 29 women with minimal (10), mild (9) and moderate (7) endometriosis. After a diagnostic laparoscopy, patients started gestrinone 2.5 mg/day 2 times a week per 6 months. Clinical …

article 1987
Late Luteal Phase Administration of RU486 for Three Successive Cycles Does Not Disrupt Bleeding Patterns or Ovulation*
·doi:10.1210/jcem-65-6-1272

RU486, a 19-nor steroid, binds with high affinity to the receptors for progesterone and glucocorticoids, blocking the actions of these hormones on their target tissues. We conducted studies to determine whether RU486 administered at the end…